Needham analyst Michael Matson reiterated a Hold rating on Medtronic, Inc. (NYSE: MDT).The analyst commented, "MDT's F1Q25 revenue and EPS ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE